This is something that is a possible risk, is a long-term possibility and is something that still needs to be researched.
Our initial conclusion was that, to date, those materials do not alter the conclusions reached by FDA about Prozac.
unfortunate as we work toward solving the complex policy and regulatory issues related to Plan B.
It's a comprehensive program involving all the parties.
